Responses
Poster Presentation
Rheumatoid arthritis - anti-TNF therapy
THU0181 Antibodies to Etanercept and Adalimumab in Rheumatoid Arthritis Inadequate Responders and Clinical Outcomes after an Active Switch to Infliximab
Compose a Response to This Article
Other responses
No responses have been published for this article.